Status:
UNKNOWN
Application of Magnesium-rich Artificial Cerebrospinal Fluid in Aneurysmal Subarachnoid Hemorrhage
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Aneurysmal Subarachnoid Hemorrhage
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Aneurysmal subarachnoid hemorrhage (aSAH) is a common type of acute hemorrhagic stroke. One of its complications, cerebral vasospasm (CVS), is the main cause of death and disability, with an incidence...
Detailed Description
From now on, participants who meet the inclusion and exclusion criteria in our hospital will be recruited in the intervention group, if they and their relatives are willing to join in the study. For t...
Eligibility Criteria
Inclusion
- Patient is between 18 and 80 years of old;
- aSAH is diagnosed by CTA, DSA or other cranial imaging examination;
- Patient is admitted to hospital within 72 hours after aSAH onset;
- Aneurysm is clipped within 36 hours after admission;
- Patient and his/her relatives are informed and agree to accept the above treatment plan.
Exclusion
- Cause of the SAH is not rupture of an intracranial aneurysm;
- Time from SAH onset to admission is longer than 72 hours;
- Time from admission to surgery is longer than 36 hours;
- The patient dose not choose clipping;
- Patient has other serious diseases, such as heart failure, kidney failure, liver failure, etc;
- Patient or his/her relatives refuse to accept the above research plan.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04358445
Start Date
March 1 2020
End Date
July 30 2022
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China, 710061